A detailed history of Crestline Management, LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Crestline Management, LP holds 19,276 shares of EW stock, worth $1.38 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,276
Holding current value
$1.38 Million
% of portfolio
0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $1.15 Million - $1.81 Million
19,276 New
19,276 $1.27 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $1.7 Million - $2.14 Million
-16,656 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $896,379 - $1.1 Million
-8,427 Reduced 33.6%
16,656 $2.16 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $2.58 Million - $3.08 Million
25,083 New
25,083 $2.84 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.